The findings could bring relief to the more than 26 million people in the United States with asthma, a chronic and complex inflammatory disease of the airways.

Super agers were 68% less likely to harbor the gene nobody wants,APOE-ε4, compared to individuals with AD dementia in the same 80+ age group.

The findings could lead to new treatments for blood cancers, which kill an estimated 23,540 people in the United States every year.

A new study identifies previously unreported protein biomarkers and candidate drug targets across six major cancer types and highlights approved drugs with potential cancer preventive effects.

In this area, treatment gaps affect up to 96% of patients, leaving millions without care. The project is funded by the National Institute of Neurological Disorders and Stroke of the NIH. 

This award honors a genetic counselor who “advances genetic counseling as a vital part of health care through education, research or public policy.